Publication Information

{'id': 'https://openalex.org/W1494195326', 'doi': 'https://doi.org/10.1111/j.1532-5415.2010.02841.x', 'title': "THE ROLE OF TUMOR NECROSIS FACTOR‐ALPHA IN COGNITIVE IMPROVEMENT AFTER PEROXISOME PROLIFERATOR‐ACTIVATOR RECEPTOR GAMMA AGONIST PIOGLITAZONE TREATMENT IN ALZHEIMER'S DISEASE", 'display_name': "THE ROLE OF TUMOR NECROSIS FACTOR‐ALPHA IN COGNITIVE IMPROVEMENT AFTER PEROXISOME PROLIFERATOR‐ACTIVATOR RECEPTOR GAMMA AGONIST PIOGLITAZONE TREATMENT IN ALZHEIMER'S DISEASE", 'publication_year': 2010, 'publication_date': '2010-05-01', 'ids': {'openalex': 'https://openalex.org/W1494195326', 'doi': 'https://doi.org/10.1111/j.1532-5415.2010.02841.x', 'mag': '1494195326', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/20722838'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/j.1532-5415.2010.02841.x', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1532-5415.2010.02841.x', 'source': {'id': 'https://openalex.org/S204183829', 'display_name': 'Journal of the American Geriatrics Society', 'issn_l': '0002-8614', 'issn': ['0002-8614', '1532-5415'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'letter', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1532-5415.2010.02841.x', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5037009613', 'display_name': 'Haruo Hanyu', 'orcid': 'https://orcid.org/0000-0003-4411-335X'}, 'institutions': [{'id': 'https://openalex.org/I158929114', 'display_name': 'Tokyo Medical University', 'ror': 'https://ror.org/00k5j5c86', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I158929114']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Haruo Hanyu', 'raw_affiliation_strings': ['Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan,'], 'affiliations': [{'raw_affiliation_string': 'Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan,', 'institution_ids': ['https://openalex.org/I158929114']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5060262806', 'display_name': 'T. Sato', 'orcid': 'https://orcid.org/0000-0002-3516-5919'}, 'institutions': [{'id': 'https://openalex.org/I158929114', 'display_name': 'Tokyo Medical University', 'ror': 'https://ror.org/00k5j5c86', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I158929114']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Tomohiko Sato', 'raw_affiliation_strings': ['Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan,'], 'affiliations': [{'raw_affiliation_string': 'Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan,', 'institution_ids': ['https://openalex.org/I158929114']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5113802641', 'display_name': 'Hirofumi Sakurai', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I158929114', 'display_name': 'Tokyo Medical University', 'ror': 'https://ror.org/00k5j5c86', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I158929114']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Hirofumi Sakurai', 'raw_affiliation_strings': ['Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan,'], 'affiliations': [{'raw_affiliation_string': 'Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan,', 'institution_ids': ['https://openalex.org/I158929114']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5112073065', 'display_name': 'Toshihiko Iwamoto', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I158929114', 'display_name': 'Tokyo Medical University', 'ror': 'https://ror.org/00k5j5c86', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I158929114']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Toshihiko Iwamoto', 'raw_affiliation_strings': ['Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan,'], 'affiliations': [{'raw_affiliation_string': 'Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan,', 'institution_ids': ['https://openalex.org/I158929114']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 4530, 'currency': 'USD', 'value_usd': 4530, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': None, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 31, 'citation_normalized_percentile': {'value': 0.95136, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 92, 'max': 93}, 'biblio': {'volume': '58', 'issue': '5', 'first_page': '1000', 'last_page': '1001'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10086', 'display_name': "Alzheimer's disease research and treatments", 'score': 0.9993, 'subfield': {'id': 'https://openalex.org/subfields/2737', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10086', 'display_name': "Alzheimer's disease research and treatments", 'score': 0.9993, 'subfield': {'id': 'https://openalex.org/subfields/2737', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11266', 'display_name': 'Neuroinflammation and Neurodegeneration Mechanisms', 'score': 0.9988, 'subfield': {'id': 'https://openalex.org/subfields/2808', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11337', 'display_name': 'Tryptophan and brain disorders', 'score': 0.9879, 'subfield': {'id': 'https://openalex.org/subfields/2803', 'display_name': 'Biological Psychiatry'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/pioglitazone', 'display_name': 'Pioglitazone', 'score': 0.9748664}, {'id': 'https://openalex.org/keywords/hyperinsulinemia', 'display_name': 'Hyperinsulinemia', 'score': 0.4897926}, {'id': 'https://openalex.org/keywords/proinflammatory-cytokine', 'display_name': 'Proinflammatory cytokine', 'score': 0.44910336}], 'concepts': [{'id': 'https://openalex.org/C2778384471', 'wikidata': 'https://www.wikidata.org/wiki/Q417765', 'display_name': 'Pioglitazone', 'level': 4, 'score': 0.9748664}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8542371}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.6327796}, {'id': 'https://openalex.org/C2778938600', 'wikidata': 'https://www.wikidata.org/wiki/Q389934', 'display_name': 'Agonist', 'level': 3, 'score': 0.5264852}, {'id': 'https://openalex.org/C187345961', 'wikidata': 'https://www.wikidata.org/wiki/Q419629', 'display_name': 'Peroxisome proliferator-activated receptor', 'level': 3, 'score': 0.5227066}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.5101769}, {'id': 'https://openalex.org/C555293320', 'wikidata': 'https://www.wikidata.org/wiki/Q12206', 'display_name': 'Diabetes mellitus', 'level': 2, 'score': 0.4962986}, {'id': 'https://openalex.org/C2780988686', 'wikidata': 'https://www.wikidata.org/wiki/Q14375936', 'display_name': 'Hyperinsulinemia', 'level': 4, 'score': 0.4897926}, {'id': 'https://openalex.org/C164027704', 'wikidata': 'https://www.wikidata.org/wiki/Q3491837', 'display_name': 'Proinflammatory cytokine', 'level': 3, 'score': 0.44910336}, {'id': 'https://openalex.org/C2777180221', 'wikidata': 'https://www.wikidata.org/wiki/Q3025883', 'display_name': 'Type 2 diabetes', 'level': 3, 'score': 0.41844812}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.33212805}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.32748556}, {'id': 'https://openalex.org/C2777391703', 'wikidata': 'https://www.wikidata.org/wiki/Q1053470', 'display_name': 'Insulin resistance', 'level': 3, 'score': 0.32584772}, {'id': 'https://openalex.org/C2776914184', 'wikidata': 'https://www.wikidata.org/wiki/Q101991', 'display_name': 'Inflammation', 'level': 2, 'score': 0.2256878}], 'mesh': [{'descriptor_ui': 'D000544', 'descriptor_name': 'Alzheimer Disease', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D003071', 'descriptor_name': 'Cognition', 'qualifier_ui': 'Q000502', 'qualifier_name': 'physiology', 'is_major_topic': True}, {'descriptor_ui': 'D047495', 'descriptor_name': 'PPAR gamma', 'qualifier_ui': 'Q000819', 'qualifier_name': 'agonists', 'is_major_topic': True}, {'descriptor_ui': 'D045162', 'descriptor_name': 'Thiazolidinediones', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D014409', 'descriptor_name': 'Tumor Necrosis Factor-alpha', 'qualifier_ui': 'Q000502', 'qualifier_name': 'physiology', 'is_major_topic': True}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000544', 'descriptor_name': 'Alzheimer Disease', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003071', 'descriptor_name': 'Cognition', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D047495', 'descriptor_name': 'PPAR gamma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077205', 'descriptor_name': 'Pioglitazone', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D045162', 'descriptor_name': 'Thiazolidinediones', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014409', 'descriptor_name': 'Tumor Necrosis Factor-alpha', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014409', 'descriptor_name': 'Tumor Necrosis Factor-alpha', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/j.1532-5415.2010.02841.x', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1532-5415.2010.02841.x', 'source': {'id': 'https://openalex.org/S204183829', 'display_name': 'Journal of the American Geriatrics Society', 'issn_l': '0002-8614', 'issn': ['0002-8614', '1532-5415'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/20722838', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/j.1532-5415.2010.02841.x', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1532-5415.2010.02841.x', 'source': {'id': 'https://openalex.org/S204183829', 'display_name': 'Journal of the American Geriatrics Society', 'issn_l': '0002-8614', 'issn': ['0002-8614', '1532-5415'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.81}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 10, 'referenced_works': ['https://openalex.org/W1542136448', 'https://openalex.org/W2085558085', 'https://openalex.org/W2099271519', 'https://openalex.org/W2105262354', 'https://openalex.org/W2109464535', 'https://openalex.org/W2131047041', 'https://openalex.org/W2147486806', 'https://openalex.org/W2156220037', 'https://openalex.org/W2166853536', 'https://openalex.org/W2914934084'], 'related_works': ['https://openalex.org/W46097970', 'https://openalex.org/W4366973446', 'https://openalex.org/W3142910047', 'https://openalex.org/W2965513749', 'https://openalex.org/W2752583015', 'https://openalex.org/W2388612811', 'https://openalex.org/W2373041972', 'https://openalex.org/W2072883796', 'https://openalex.org/W2057743727', 'https://openalex.org/W1967713685'], 'abstract_inverted_index': {'To': [0], 'the': [1, 11, 58, 76, 98, 104, 110, 246, 291, 295, 338, 349, 356, 365, 388, 395, 409, 424, 450, 477, 493, 623, 636, 650, 657, 663], 'Editor:': [2], 'Some': [3], 'clinical': [4], 'trials': [5], 'have': [6, 608, 665], 'shown': [7], 'that': [8, 33, 508, 525, 561, 662], 'agonists': [9, 527, 628], 'of': [10, 36, 70, 78, 80, 97, 106, 112, 164, 173, 266, 300, 305, 318, 320, 510, 552, 606, 626, 642, 652, 672, 687, 694, 698, 708], 'nuclear': [12], 'receptor': [13, 16], 'peroxisome': [14], 'proliferator-activator': [15], 'gamma': [17], '(PPRAγ)': [18], 'improve': [19], 'cognition': [20, 44, 113], 'and': [21, 45, 197, 200, 209, 217, 229, 257, 269, 282, 294, 352, 380, 445, 459, 583, 621, 659, 684, 689, 692, 696, 704, 710], 'memory': [22], 'in': [23, 47, 75, 109, 117, 129, 169, 185, 298, 329, 348, 355, 367, 387, 394, 403, 408, 417, 427, 434, 442, 476, 492, 542, 571, 578, 585, 588, 646], 'patients': [24, 48, 118, 130, 141, 166, 174], 'with': [25, 38, 49, 52, 84, 119, 131, 135, 142, 150, 175, 375, 432, 465, 518, 567, 574, 675], "Alzheimer's": [26, 270], 'disease': [27, 586], '(AD).1,2': [28], 'A': [29, 122, 521, 557], 'pilot': [30], 'study': [31, 100, 179, 523, 559, 682], 'demonstrated': [32], '6': [34, 211, 385, 473], 'months': [35], 'treatment': [37, 73, 116, 149, 515, 591], 'a': [39, 85, 170, 361, 414, 540, 604], 'PPARγ': [40, 526, 614, 627], 'agonist,': [41], 'pioglitazone,': [42], 'improved': [43], 'hyperinsulinemia': [46], 'mild': [50, 120, 132, 176], 'AD': [51, 133, 619], 'type': [53, 136], 'II': [54, 137], 'diabetes': [55, 138], 'mellitus,3': [56], 'although': [57], 'reason': [59], 'for': [60, 601, 635], 'these': [61, 165], 'benefits': [62, 600], 'is': [63, 565, 629], 'not': [64, 159, 441, 491], 'fully': [65], 'understood.': [66], 'In': [67, 187], 'animal': [68], 'models': [69], 'AD,': [71], 'pioglitazone': [72, 115, 151, 156, 292, 350, 389, 478, 514], 'resulted': [74], 'reduction': [77, 509], 'numbers': [79], 'activated': [81], 'microglia': [82], 'associated': [83, 134, 517, 566], 'lower': [86], 'plaque': [87], 'burden,': [88], 'partly': [89], 'by': [90, 532, 554, 656], 'suppressing': [91], 'proinflammatory': [92], 'gene': [93], 'expression.4': [94], 'The': [95, 178, 220, 644], 'aim': [96], 'present': [99], 'was': [101, 127, 243, 360, 406, 413, 506, 516], 'to': [102, 148, 484, 500, 545, 549, 592, 617], 'investigate': [103], 'role': [105, 541], 'inflammatory-associated': [107], 'proteins': [108], 'improvement': [111], 'after': [114, 513], 'AD.': [121, 177, 602, 640], '6-month,': [123], 'randomized,': [124], 'open-controlled': [125], 'trial': [126], 'conducted': [128], 'mellitus.': [139], 'Thirty-four': [140], 'probable': [143], 'AD5': [144], 'were': [145, 167, 205, 224, 234, 286, 327], 'randomly': [146], 'assigned': [147], '15': [152], 'mg': [153], 'daily': [154], '(n=17,': [155, 160], 'group)': [157], 'or': [158, 316, 334, 668], 'control': [161, 296, 357, 396, 494], 'group).': [162], 'Twenty-six': [163], 'included': [168], '2009': [171], 'study3': [172], 'protocol': [180], 'has': [181, 648, 660], 'been': [182], 'described': [183], 'elsewhere': [184], 'detail.3': [186], 'this': [188, 676], 'study,': [189, 451], 'plasma': [190, 280, 332, 457], 'cytokines,': [191, 281, 333], 'including': [192], 'tumor': [193], 'necrosis': [194], 'factor-alpha': [195], '(TNF-α)': [196], 'interleukin-6': [198], '(IL-6),': [199], 'high-sensitivity': [201], 'C-reactive': [202], 'protein': [203], '(hs-CRP),': [204], 'quantified': [206], 'at': [207, 383, 471, 630], 'baseline': [208, 376], 'Month': [210, 341, 384, 472], 'using': [212, 245], 'commercially': [213], 'available': [214], 'enzyme-linked': [215], 'immunoassays': [216], 'nephrometry,': [218], 'respectively.': [219, 232], 'minimum': [221], 'detectable': [222], 'concentrations': [223], '0.5': [225], 'pg/mL,': [226, 228], '0.2': [227], '0.02': [230], 'mg/dL,': [231], 'Values': [233], 'expressed': [235], 'as': [236], 'means': [237], '±': [238, 482, 486, 498, 502], 'standard': [239], 'deviations.': [240], 'Statistical': [241], 'analysis': [242, 691], 'performed': [244], 'Student': [247], 't-test,': [248], 'chi-square': [249], 'test,': [250, 253, 256], 'Mann-Whitney': [251], 'U': [252], 'Wilcoxon': [254], 'signed-rank': [255], 'Spearman': [258], 'rank': [259], 'correlation': [260], 'test.': [261], 'Table': [262], '1': [263], 'shows': [264], 'comparisons': [265], 'subject': [267], 'characteristics': [268], 'Disease': [271], 'Assessment': [272], 'Scale': [273], 'Cognitive': [274], 'Subscale,': [275], 'Japanese': [276], 'version': [277], '(ADAS-Jcog)': [278], 'scores,': [279, 331], 'hs-CRP': [283, 335, 381, 446], 'changes.': [284], 'There': [285, 359, 412], 'no': [287, 324, 399, 666], 'significant': [288, 325, 362, 401, 415], 'differences': [289, 326], 'between': [290, 337, 364, 423], 'group': [293, 297, 351, 479, 495], 'terms': [299], 'age,': [301], 'sex,': [302], 'education,': [303], 'duration': [304], 'symptoms,': [306], 'Mini-Mental': [307], 'State': [308], 'Examination': [309], '(MMSE)': [310], 'score,': [311], 'apolipoprotein': [312], 'E': [313], 'ɛ4': [314], 'status,': [315], 'prevalence': [317], 'use': [319], 'donepezil.': [321], 'At': [322, 340], 'baseline,': [323, 466], 'found': [328, 407, 507, 524], 'ADAS-Jcog': [330, 343, 368, 428], 'levels': [336, 382, 447, 470, 512, 595], 'groups.': [339, 411, 425], '6,': [342], 'scores': [344, 429], 'had': [345], 'decreased': [346, 386, 474], 'significantly': [347, 354, 430, 475], 'increased': [353, 393], 'group.': [358], 'difference': [363, 416], 'groups': [366, 453], 'score': [369], 'changes': [370, 420, 433], '(Month': [371, 421], '6–baseline).': [372], 'When': [373, 463], 'compared': [374, 464], 'values,': [377], 'TNF-α,': [378, 537], 'IL-6,': [379], 'group,': [390, 397], 'whereas': [391], 'they': [392], 'but': [398, 440, 490], 'statistically': [400], 'change': [402], 'either': [404], 'value': [405], 'two': [410], 'TNF-α': [418, 435, 511, 564, 579, 594], 'level': [419], '6–baseline)': [422], 'Changes': [426], 'correlated': [431], '(correlation': [436], 'coefficient': [437], '(r)=0.38,': [438], 'P=.04)': [439], 'IL-6': [443], '(r=0.19)': [444], '(r=0.14).': [448], 'During': [449], 'both': [452], 'showed': [454, 560], 'stable': [455], 'fasting': [456, 467], 'glucose': [458], 'hemoglobin': [460], 'A1c': [461], 'levels.': [462], 'immunoreactive': [468], 'insulin': [469], '(from': [480, 496], '7.8': [481], '3.9': [483], '5.7': [485], '2.4': [487], 'μU/mL,': [488], 'P<.05)': [489], '6.7': [497], '4.8': [499], '6.5': [501], '2.9': [503], 'μU/mL).': [504], 'It': [505], 'cognitive': [519, 569], 'improvement.': [520], 'previous': [522], 'inhibit': [528], 'Aβ': [529], 'production': [530], 'stimulated': [531], 'inflammatory': [533], 'cytokines.6': [534], 'Proinflammatory': [535], 'cytokine': [536], 'which': [538, 613], 'plays': [539], 'immune': [543], 'system': [544], 'brain': [546], 'communication,': [547], 'contributes': [548], 'an': [550], 'exacerbation': [551], 'neurodegeneration': [553], 'microglial': [555], 'activation.': [556], 'recent': [558], 'high': [562], 'serum': [563], 'long-term': [568], 'decline': [570], 'community-dwelling': [572], 'subjects': [573, 688, 709], 'AD.7': [575], 'An': [576], 'increase': [577], 'regulates': [580], 'synaptic': [581], 'scaling': [582], 'results': [584], 'progression': [587], 'AD.8': [589], 'Therefore,': [590], 'reduce': [593], 'might': [596, 615], 'provide': [597], 'some': [598], 'therapeutic': [599], 'Although': [603], 'number': [605], 'studies': [607], 'examined': [609], 'potential': [610], 'mechanisms': [611], 'through': [612], 'act': [616], 'ameliorate': [618], 'pathogenesis': [620], 'progression,': [622], 'anti-inflammatory': [624], 'action': [625], 'least': [631], 'one': [632], 'plausible': [633], 'explanation': [634], 'beneficial': [637], 'effect': [638], 'on': [639], 'Conflict': [641], 'Interest:': [643], 'editor': [645], 'chief': [647], 'reviewed': [649], 'conflict': [651], 'interest': [653], 'checklist': [654], 'provided': [655], 'authors': [658, 664], 'determined': [661], 'financial': [667], 'any': [669], 'other': [670], 'kind': [671], 'personal': [673], 'conflicts': [674], 'paper.': [677], 'Author': [678], 'Contributions:': [679], 'Haruo': [680], 'Hanyu:': [681], 'concept': [683], 'design,': [685], 'acquisition': [686, 707], 'data,': [690, 695], 'interpretation': [693], 'preparation': [697], 'letter.': [699], 'Tomohiko': [700], 'Sato,': [701], 'Hirofumi': [702], 'Sakurai,': [703], 'Toshihiko': [705], 'Iwamoto:': [706], 'data': [711], 'analysis.': [712], "Sponsor's": [713], 'Role:': [714], 'None.': [715]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1494195326', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 3}, {'year': 2022, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 4}, {'year': 2020, 'cited_by_count': 2}, {'year': 2019, 'cited_by_count': 2}, {'year': 2018, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 4}, {'year': 2014, 'cited_by_count': 2}, {'year': 2013, 'cited_by_count': 4}, {'year': 2012, 'cited_by_count': 5}], 'updated_date': '2024-12-13T08:00:04.336448', 'created_date': '2016-06-24'}